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Cyclic adenosine monophosphate and cyclic guanosine monophosphate are universal intracellular
messengers whose concentrations are regulated by molecular networks comprised of diﬀerent
isoforms of the synthases adenylate cyclase or guanylate cyclase and the phosphodiesterases which
degrade these compounds. In this paper, we employ a systems biology approach to develop
mathematical models of these networks that, for the ﬁrst time, take into account the diﬀerent
biochemical properties of the isoforms involved. To investigate the mechanisms underlying the
joint regulation of cAMP and cGMP, we apply our models to analyse the regulation of cilia beat
frequency in Paramecium by Ca2+. Based on our analysis of these models, we propose that the
diversity of isoform combinations that occurs in living cells provides an explanation for the huge
variety of intracellular processes that are dependent on these networks. The inclusion of both
G-protein receptor and Ca2+-dependent regulation of AC in our models allows us to propose a
new explanation for the switching properties of G-protein subunits involved in nucleotide
regulation. Analysis of the models suggests that, depending on whether the G-protein subunit is
bound to AC, Ca2+ can either activate or inhibit AC in a concentration-dependent manner. The
resulting analysis provides an explanation for previous experimental results that showed that
alterations in Ca2+ concentrations can either increase or decrease cilia beat frequency over
particular Ca2+ concentration ranges.
Introduction
Cyclic 30,50 adenosine monophosphate (cAMP) and cyclic
30,50 guanosine monophosphate (cGMP) were ﬁrst identiﬁed
as intracellular mediators in the 1950s.1 Intracellular signalling
via the cAMP and cGMP nucleotides is involved in many
areas of animal cell biology and is an important area of
research. Conceptual models of cAMP concentration regula-
tion have undergone signiﬁcant changes in recent years as
more details of the role of adenylate cyclases (ACs) and cyclic
nucleotide phosphodiesterase (PDE) in cAMP regulation have
been reported.2–4 Both these enzymes exhibit a continuum of
isoforms with unique biochemical properties, which are
expressed in various combinations within both single and
multicellular organisms. Such isoforms are also sometimes
referred to as gene products,5 and are expressed by somewhat
diﬀerent gene groups or may arise from the same gene by
alternative splicing.
Dictyostelium cells contain three distinct AC isoforms6 and
mammalian cells can express ten diﬀerent major AC gene
isoforms.5 As well as having diﬀerent structures and biochemical
properties, it is now well-established that diﬀerent AC gene
products can be either activated or inhibited by G-protein7
and Ca2+ pathways.8 The ten AC genes can be divided into
ﬁve families according to their structural and activation
properties.5 The Ca2+–CaM activated isoforms are ACI,
ACIII and ACVIII. ACII, ACIV and ACVII are activated
by Gbg. ACV and ACVI are inhibited by Gai isoforms
(Ga0, Gai1, Gai2, Gai3, and Gaz,) and Ca
2+ ions. There
is an ongoing debate as to whether the ACV and ACVI
isoforms are inhibited by Ca2+ directly or via CaM.9 The last
membrane-bound ACIX isoform is the most divergent from
the other eight membrane-bound isoforms. The last soluble
isoform is similar to the AC found in Anabaena.10
In combination with synthesis by AC and guanylate cyclase,
PDEs regulate the levels of cAMP and cGMP by degradation
of the cyclic molecules, and these enzymes are expressed in a
wide range of organisms: Trypanosoma,11,12 Dictyostelium,13
Drosophila14 and Homo sapiens.15,16 Eleven families of PDE in
various species, each containing several isoforms with diverse
structures and biochemical properties, have now been identi-
ﬁed in the literature.17 The calcium and calmodulin-dependent
PDEI family was one of the ﬁrst to be identiﬁed.18 The speciﬁc
property of PDEII enzymes is that they are activated by
cGMP binding.19 cAMP hydrolysis by the PDEIII family,
unlike in the case of PDEII, is inhibited by cGMP. PDEIV,
PDEVII and PDEVIII are highly sensitive to cAMP as a
substrate, with Km being of the order of magnitude of 1mM
and lower.20–22 PDEV was originally identiﬁed in platelets23
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and later become a target for a number of drugs regulating
vascular smooth muscle contraction.24,25 PDEV is charac-
terised by relative speciﬁcity to cGMP rather than to cAMP.
PDEVI is also known as a photoreceptor phosphodiesterase
due to its expression in mammalian retina. PDEIX has the
highest aﬃnity for cGMP and has been proposed as a reg-
ulator of cGMP signaling.26,27 PDEX is not as well character-
ized as some other PDE families. However, it has been
reported that PDEX is more cAMP rather than cGMP
speciﬁc.28 PDEXI is the most recently discovered phospho-
diesterase29 and has been reported to hydrolyse both cAMP
and cGMP without any preference for either nucleotide.
It is now well established that many of the intracellular
eﬀects of cAMP are mediated by cAMP-dependent kinase
(PKA). PKA catalyzes the transfer of the terminal phosphate
group from ATP to serines and threonines of target proteins,
hence modulating their activity. The phosphorylation of dif-
ferent substrates by PKA in various cells certainly provides a
partial explanation for the variety of cAMP eﬀects in diﬀerent
cellular systems. In this paper, we use a structural systems
biology approach to further investigate this issue, and propose
that the multitude of AC, GC and PDE gene group products
which may occur in living cells provides another important
mechanism for cAMP concentration-dependent diﬀerential
regulation of intracellular events. The proposed approach
can therefore be regarded as a natural extension of previous
approaches to modelling cAMP regulation,30,31 which allows
us to generate isoform speciﬁc cAMP concentration proﬁles
and study isoform speciﬁc regulatory eﬀects.
An important, but perhaps insuﬃciently recognized, pro-
blem in nucleotide signalling is the convergence and mutual
inﬂuence of Ca2+ and G-protein pathways on cAMP produc-
tion. It is not clear to what extent each of these pathways
contributes to the shaping of the output AC response and
subsequent modulation of the cAMP-dependent eﬀects across
the cell. Previous mathematical modelling studies have largely
focused on the separate eﬀects of either G-protein or Ca2+
signals on cAMP production.4,31–36 We aimed here to develop
a model to include the eﬀects of AC regulation by both Ca2+
and G-protein dependent signals and thus to elucidate the
interplay between these two major pathways modulating AC,
and hence cAMP, concentrations within the framework of the
network shown in Fig. 1. By analysing this model, we are able
to predict various potential outputs for cAMP dependence on
Ca2+ and G-protein signals and we can thus compare the
model predictions for nucleotide signalling with a number of
experimental studies, in order to identify potential cellular
mechanisms governing the interplay between Ca2+ and
G-protein pathways. In this study, we decided to select a
number of AC isoforms that have been elucidated experimen-
tally and represent diﬀerent types of concentration proﬁles:
activation, inhibition, bell-shaped dependence and reverse bell
shaped dependence.
cGMP acts as a second messenger in a similar way to cyclic
AMP, but exhibits several notable diﬀerences. In particular,
signiﬁcant activity of cGMP is observed at higher Ca2+
concentrations.37 cGMP synthesis is catalyzed by GC, which
converts GTP to cGMP, and is hydrolysed by cyclic nucleotide
phosphodiesterases (PDE I–IV) into 50-GMP. Both cGMP
and cAMP have been reported to be involved in cell migration
and chemotaxis mechanisms in unicellular organisms such as
Dictyostelium38–40 and Paramecium.41–43 Currently, however,
there is limited understanding of the nature and extent of
crosstalk between these two pathways. To investigate this
issue, we aimed to develop a model incorporating Ca2+
dependent alterations of both cAMP and cGMP. The model
predictions are tested against multiple sets of experimental data
on the complementary roles of cAMP and cGMP-dependent
cilia beat in Paramecium, and allow us to propose a new
explanation for how intracilia Ca2+ and nucleotide concen-
tration alterations translate to cilia beat frequency and the
movement that deﬁnes the trajectory of Paramecium motion.
Results
Isoform-speciﬁc modelling reveals the diversity of cAMP
concentration proﬁles
Our isoform-based model predicts that the diﬀerences in
cAMP proﬁles among various cell types are at least partly
due to the many diﬀerent combinations of AC and PDE
isoforms expressed in particular types of cells and tissues.
Various combinations of AC and PDE isoforms, each with
their own unique biochemical properties, can provide a multi-
tude of cell speciﬁc concentration proﬁles. In this section, we
demonstrate how the AC and PDE pairs regulated by Ca2+
and G-protein subunits form cAMP concentration proﬁles
(Fig. 1) and tune physiological eﬀects. Model predictions for
ACI, ACII and PDEI isoform activation (Fig. 2A) by Ca2+
are compared against experimental data from the litera-
ture44,45 in Fig. 2B. The combination of ACI and ACII with
PDEI in our model allows quantitative predictions concerning
Fig. 1 Signalling network for intracellular cAMP regulation: cyclic
AMP is synthesised by AC and hydrolysed by PDE enzymes. The
activities of ACs are regulated by Ca2+ via CaM proteins as well as by
G-protein subunits. PDE is activated by intracellular Ca2+ concentra-
tion via CaM. The level of cAMP is regulated by extracellular signals
through the GPCRs as well as by intracellular Ca2+ variations.
44 | Mol. BioSyst., 2009, 5, 43–51 This journal is c The Royal Society of Chemistry 2009
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intracellular cAMP concentrations to be made. Eqn (6) and (7)
(see Experimental) have been employed to combine the
Ca2+–CaM-dependent PDEI isoform with the Ca2+-dependent
AC isoforms. Fig. 2C–H show the resulting intracellular
cAMP concentration proﬁles predicted by the model. In
addition to the clear dependence of cAMP levels on the unique
biochemical properties of the AC and PDE isoforms, the
shape of the cAMP concentration proﬁle is seen to be highly
sensitive to the values of the CaM-AC dissociation constants.
Indeed, variation of these parameters in the model resulted in
dramatic alterations in cAMP proﬁles even for the same AC
and PDE isoforms (Fig. 2C–2H). The same ACI and PDEI
enzyme pair revealed variable steady-state cAMP concentra-
tion proﬁles when the CaM–PDEI dissociation constants were
equal to 0.02 mM, 10 nM and 1 mM on Fig. 2C, 2D, and 2E,
respectively. Similarly the same variability of the CaM–PDEI
equilibrium dissociation constants produced qualitatively dif-
ferent cAMP concentration proﬁles for the ACII and PDEI
enzymes on Fig. 2F, 2G, and 2H.
Some AC isoforms interact with G-protein subunits that
transmit extracellular signals via G-protein coupled receptors
(Fig. 3A). We used our model to analyse the intracellular
cAMP concentration dependence as a function of these
G-protein signals. Fig. 3B compares the model responses
against experimental data for the ACI and ACII regulation
curves by G-protein subunits. Since the G-protein mediated
signals do not always assume simultaneous Ca2+ stimulation,
we have chosen to use the steady-state level of Ca2+-dependent
PDEI activity in combination with G-protein activated AC
isoforms shown in Fig. 3B. Fig. 3C–E shows the range of
intracellular cAMP concentration proﬁles achieved by the
G-protein mediated signals. The data suggests that G-protein
mediated signals can cause intracellular cAMP concentration
to decrease (Fig. 3D), increase (Fig. 3E), or even exhibit a
reversed bell-shaped dependence (Fig. 3C).
Interactions between G-protein and Ca2+/CaM signalling
pathways switch cAMP concentrations
We next employed our model to investigate the level of
interaction between the G-protein and Ca2+ signalling path-
ways. As discussed above, AC can be activated by Ca2+–CaM
complexes as well as by G-protein subunits. While the dose-
dependent responses have been characterized for both Ca2+
and G-protein pathways, it is not always clear if and how
interactions between these two diﬀerent pathways occur. Since
both Ca2+ and G-protein mediated signals can activate or
inactivate AC, it is of interest to establish what state the AC is
Fig. 2 Model predictions of cAMP dependence on Ca2+ concentration: (A) Schematic diagram of cAMP regulation by Ca2+ via the CaM, AC
and PDE proteins. (B) Data for ACI, ACII and PDEI isoforms from44,45 shown as circles. The solid line in each case shows the model dependence
on Ca2+. The ACI–PDEI and ACII–PDEI isoform pairs are used to study the cyclic AMP concentration proﬁles. The steady-state cAMP
dependence on Ca2+ concentration is predicted for the ACI–PDEI enzyme pair (C, D and E) and for the ACII–PDEI pair (F, G and H). The
equilibrium dissociation constant for CaM–PDEI interaction has been set equal to: 0.02 mM (B, E), 10 nM (C, F), and 1 mM (D, G). The model
predictions illustrate how the diverse range of cAMP concentration proﬁles may be achieved due to the combinations of AC and PDE isoforms
with unique biochemical properties.
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likely to be at if there is an inhibition signal through the
G-protein and activation signal via the Ca2+ pathway.
Building on work on nucleotide signalling showing that AC
was activated by G-protein subunits,35,46,47 it was found that
there are many other regulators of AC with various activation
patterns. In addition to regulation by G-protein subunits, the
activities of AC are also modulated by Ca2+, phosphorylation,
glycosylation and many other regulatory phenomena.48 An
interesting example of a molecular system with joint Ca2+-
CaM and G-protein dependent AC regulation is the network
underlying cAMP production in Dictyostelium.49 Indeed, in
these cells the interplay between Ca2+ and GPCR induced
signals appears to govern the direction and the rate of migra-
tion in chemotaxis.50 Fig. 4A shows a schematic diagram for
AC interactions with Ca2+, Ca2+/CaM and with G-protein
subunits. Although AC has two ATP binding domains, it has
been shown that these domains are inactive separately and
require dimerization for AC activity.51 This fact allows us to
introduce a simpliﬁcation and consider a model of AC with
one catalytic centre that describes the activity of the two
domains. The multiple G-protein subunits (15a, 5b and 13g)
together with the nine membrane bound AC isoforms raise the
issue of selectivity between the interacting partners.52 We
showed previously that structural selectivity can be comple-
mented by ligand concentration-based selective target activa-
tion.53 In this case, however, the selectivity of the regulation
achieved appears to be due to the combination of signals from
separate pathways. For example, G-protein subunit binding
may inhibit or activate AC, depending on the AC isoform and
the subunit. At the same time, the binding of the same subunit,
in combination with AC phosphorylation or by binding to a
Ca2+–CaM pair, may cause a diﬀerent degree of AC activity,
produce more or less cAMP and as a result induce a diﬀerent
intracellular eﬀect. In order to investigate the relationship and
the inﬂuence of the two regulatory pathways, we analysed an
example of the Ca2+–CaM and G-protein subunit interactions
with AC. In the most general case there is no strong reason to
assume that the actual activity of AC is simply the sum or
multiplication of activities mediated by the G-protein subunits
and Ca2+–CaM separately. In other words, binding of one of
the modulators to the AC is likely to have an impact on the
overall molecular conformation and may thus lead to altera-
tions in its aﬃnity to another modulator. Since the AC activity
may not be just a linear combination of the G-protein and
Ca2+ pathway induced signals, we considered the overall state
of the AC molecules and employed mathematical modelling to
analyse a range of potential outcomes.
Fig. 4 shows model predictions for the variety of AC
activation modes by Ca2+ in diﬀerent conformational states.
The results of this analysis suggest that Ca2+ can be either an
activator or inhibitor of AC, depending on the AC conforma-
tion in the complex with G-protein subunits. The binding of
G-proteins alters the conformation of the molecule, changes
the Ca2+, Ca2+–CaM and substrate interaction constants
with AC and thereby modulates the activity state. The pre-
dicted probabilities for AC molecules to be in complexes with
G-protein subunits and Ca2+–CaM complexes are shown in
Fig. 4B as a function of Ca2+ concentration. As shown in
Fig. 4, the proportion of non Ca2+/CaM bound AC species
decreases with the elevation of Ca2+ concentration, whereas
the proportion of other species gradually increases. The sum of
the activities for individual AC species is represented in
Fig. 4C with low and high concentrations of G-protein sub-
units. The model predicts that the switch between Ca2+-
dependent activation and inhibition of AC is due to the
interaction with G-proteins. G-protein subunits shift the
balance between the number of AC conformations which
increase with Ca2+ and the number of those that decrease
with Ca2+. Thus, Ca2+ signals can both activate or inhibit AC
depending on the presence or absence of speciﬁc G-protein
subunits. The diﬀerence between the AC isoforms in terms of
their Ca2+ and G-protein mediated properties appears to be in
the variability of aﬃnity constant pairs to the substrate and to
the G-protein subunits. Fig. 4B, 4C, 4D and 4E show alter-
native combinations of dissociation constants of AC to both
substrates and G-proteins. An interesting ﬁnding is that the
model predicts that there can exist cases where Ca2+ always
inhibits (Fig. 4C), does not aﬀect (Fig. 4D), or always activates
(Fig. 4E) AC molecules. At the same time, the G-protein
mediated signals modulate the amplitude of the Ca2+-depen-
dent responses. Eﬀectively, G-protein subunits deﬁne the state
of the AC, depending on which cAMP production can be
Fig. 3 Model predictions of cAMP dependence on G-protein subunit
concentrations: (A) Schematic diagram of cAMP regulation by G-protein
subunits via the AC isoforms. (B) The dependence of ACI, ACII and
PDEI isoforms activity on G-protein subunits from7 shown as circles.
The solid line in each case shows the model prediction. The model
predictions for combinations of ACI regulated by Ga, Gbg subunits
and ACII with PDE ﬁxed at a basal activity level suggest that
extracellular signals via the GPCRs can form a range of intracellular
cAMP concentration proﬁles: reversed bell-shape (C), inhibition (D)
or activation (E).
46 | Mol. BioSyst., 2009, 5, 43–51 This journal is c The Royal Society of Chemistry 2009
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either Ca2+ inhibited (Fig. 4C), Ca2+ independent (Fig. 4D)
or Ca2+ activated (Fig. 4E).
Complementary regulation of cilia beat frequency by cAMP
and cGMP
The steady-state concentration of cGMP as a function of Ca2+
concentration predicted by eqn (8) in our model (see Experi-
mental) has been validated against the experimental data
from.37 It is clear from the experimental data that some GC
and PDE isoform pairs also produce a bell-shaped dependence
of cGMP on Ca2+ concentration, in a similar way as AC and
PDE do with cAMP. However, the peak cGMP concentration
is reached at a signiﬁcantly higher value of Ca2+ compared to
the maximum cAMP concentration (Fig. 5B). This similarity in
the shape of the concentration-dependent curves and at the
same time the diﬀerence in the Ca2+ concentration correspond-
ing to the highest nucleotide levels is rather intriguing, and may
shed light on the mechanisms involved in synchronised intra-
cellular nucleotide signalling.
To investigate the issue of joint regulation by cAMP and
cGMP, we considered an experimental system that requires
the alteration of both cAMP and cGMP nucleotides in a
Ca2+-dependent manner. Multiple studies have found that
cilia beat frequency (CBF) is regulated by cAMP phosphoryl-
ation of dynein subunits.41,54,55 cGMP-dependent kinase has
also been shown to be involved in CBF regulation.56–58 Ca2+
shapes both cAMP and cGMP intracilia concentrations
and it is well established that it controls the cilia beat.59 In
Paramecium, elevation of Ca2+ is reported to decrease cilia
beat to the point at which the direction of beat is reversed.60
However, a further rise in Ca2+ leads to increased CBF,61 and
the results of this study generally revealed a highly complex
Fig. 4 AC regulation by Ca2+ and G-protein pathways: (A) Schematic representation of the AC activity regulation network. Various AC
isoforms are aﬀected by Ca2+ and G-protein pathway signals according to their unique structures and corresponding biochemical properties. The
model elucidates the link between the eﬀect of Ca2+ and G-proteins on cAMP production via the regulation of AC. The model predicts four
diﬀerent potential scenarios for AC regulation by Ca2+ in the presence of G-protein subunits. (B) G-proteins may possess switching functionality.
The model predicts that AC is inhibited by Ca2+ in the absence of G-proteins but can become insensitive to Ca2+ alterations when the number of
G-protein subunits increases. Further increase of G-protein subunits produces a switching eﬀect so that AC is now activated by Ca2+. The analysis
of other potential scenarios for the interactions of G-protein and Ca2+ pathways reveals that AC can be completely insensitive to Ca2+ (D) or
Ca2+ can inhibit (C) or activate (E) AC, over the full physiological range of G-protein subunit concentrations.
Fig. 5 Cilia beat frequency dependence on Ca2+ concentration in
Paramecium: (A) Schematic diagram representing the molecular net-
work regulating CBF. Dynein subunits responsible for creating cilia
movement are phosphorylated by cAMP and cGMP-dependent ki-
nases. The levels of cAMP and cGMP are regulated by AC, GC, and
PDE. The activities of these enzymes are regulated by CaM in a Ca2+-
dependent manner. Mg2+ binds competitively to the Ca2+ binding
sites on CaM. (B) The comparison of the nucleotide concentrations
and the CBF dependence on Ca2+ concentrations. The data for
CBF,61 AC69 and GC37 is shown as circles, squares, and pentagons,
respectively. Both experimental data and the model predictions
suggest that CBF almost superimposes on the sum of AC and GC
steady-state curves. The only diﬀerence is the shift along the Ca2+
concentration, which can be explained by the diﬀerence in Mg2+
concentration at which the experiments took place.
This journal is c The Royal Society of Chemistry 2009 Mol. BioSyst., 2009, 5, 43–51 | 47
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CBF dependence on the Ca2+ concentration. In mammals,
increases in Ca2+ concentration almost always intensify cilia
beat62–65 and reduced Ca2+ appears to diminish CBF.64 In
spite of these and other experimental studies, there still
appears to be considerable disagreement on the precise
mechanisms of Ca2+ action in this system.56,66
We have used the mathematical model for Ca2+-dependent
cAMP and cGMP metabolism developed in this study to
investigate the underlying molecular mechanism of CBF reg-
ulation in Paramecium. The model predictions for cAMP and
cGMP concentration (Fig. 5B) according to eqn (6) and (8)
were superimposed on one graph (Fig. 5B) and compared with
the experimentally measured dependence of CBF on Ca2+
concentration in Paramecium cells. Previous studies have
already demonstrated how phosphorylation of dynein
subunits by cAMP- and cGMP-dependent enzymes translates
into cilia movement.67,68 Here we compare the nucleotide
concentrations in comparison with CBF, presuming that the
degree of cilia movement is proportional to the nucleotide
concentration, via the phosphorylation of dynein protein by
protein kinases.
The superimposition of the sum of the cAMP and cGMP
concentration proﬁles predicted by the model and the CBF as
a function of Ca2+ reveals a striking overlay of the two pieces
of data. The only diﬀerence is the shift along the Ca2+
concentration. This diﬀerence can be explained by the fact
that the Mg2+ concentrations used in the sets of experiments
were signiﬁcantly diﬀerent. It has been shown before that
Mg2+ ions can competitively bind to the same Ca2+ binding
sites of CaM protein and make it require higher Ca2+ con-
centrations to achieve the same eﬀects. With the amendment
to Mg2+ concentration, the sum of the nucleotides closely
reproduces the CBF dependence on intracilia Ca2+ concen-
tration. This observation, emerging from the combination of
the nucleotide model predictions with experimental data,
provides an alternative to the previously discussed roles of
cAMP and cGMP in cilia beat. First, the model clariﬁes how
and why the alterations of Ca2+ concentrations can both
increase or decrease CBF at speciﬁc Ca2+ concentration
ranges. Second, it is reasonable to suggest that cAMP and
cGMP operate in combination, rather than having unique and
separate roles in CBF.
Discussion
This study elucidates some fundamental properties of the
cAMP and cGMP regulatory systems using a structural
systems biology approach. Our model allows a detailed ana-
lysis of the AC, GC and PDE isoform speciﬁc nucleotide
distribution as a function of intracellular Ca2+ concentration
and G-protein subunits. This analysis in turn allows us to
distinguish the diverse modes of cAMP concentration regula-
tion emerging from combinations of AC and PDE isoforms
with unique structural properties (Fig. 2 and 3). The possibility
of inhibition, bell-shaped, reverse bell-shaped and sigmoidal
saturation of cAMP as a function of intracellular Ca2+
concentration suggests a potential explanation for mechan-
isms of intracellular selective cAMP-dependent signalling. In a
previous work, we demonstrated that conformation-speciﬁc
target activation is a mechanism for selective activation of
multiple targets by multisite proteins.53 The non-bound, inter-
mediate and fully saturated multisite protein conformations
are mostly present at diﬀerent ranges of Ca2+ concentration.
In the case of nucleotide signalling, the predicted and observed
concentration proﬁles as a function of Ca2+ and G-protein
subunits (Fig. 4) can be interpreted as a mechanism for
selective nucleotide signalling. Given that the cAMP-dependent
PKA kinase phosphorylates so many diﬀerent targets, a
fundamental question arises as to how it targets its phosphoryl-
ation targets selectively. Structural studies demonstrate com-
plementary protein surfaces are responsible for docking and
phosphorylation but do not explain why diﬀerent proteins or
phosphorylation sites would be phosphorylated separately by
the same cAMP-dependent PKA kinase. PKA has two cAMP
binding sites and according to our previous work it could be
selectively active to its phosphorylation targets in a complex
with variable numbers of cAMP molecules bound. The diver-
sity of possible cAMP concentration proﬁles demonstrated by
this study provides additional potential mechanisms for selec-
tive regulation.
The model predictions for simultaneous AC activation by
both Ca2+ and G-proteins illuminate the impact of these two
signals on cAMP concentration. We investigated potential
scenarios of Ca2+ inﬂuence on the AC enzymatic activity in
the presence and absence of G-protein subunits. The experi-
mental data suggest that both Ca2+ and G-protein subunits
may act as either inhibitors or activators of AC under diﬀerent
conditions (Fig. 4). Our mathematical modelling-based analy-
sis shows that one potential possibility is that the state of AC
changes when G-protein subunits bind to the molecule.
Fig. 3B and 3C show that Ca2+ can modulate AC enzymatic
activity in activatory or inhibitory fashion depending on
whether G-protein subunits are bound to the AC protein. It
has been proposed that multiple regulators of AC form
patterns resulting in variability of AC activity.3,48 Here we
demonstrate the underlying mechanism and eﬀects of Ca2+
and G-proteins on cAMP concentration via the AC regulation.
The resulting analysis allows us to propose a new explanation
for the switching properties of G-protein subunits involved in
nucleotide regulation. In particular, we show that, depending
on whether the G-protein subunit is bound to AC, Ca2+ can
either activate or inhibit AC in a concentration-dependent
manner, in agreement with recent experimental results.3,4
The nature of the complementary regulation of cilia beat
frequency in Paramecium cells by cAMP and cGMP has also
been clariﬁed by our study. While it has been known for some
time that both nucleotides are required for cilia beat, little has
been known about the level and nature of interaction between
them. Our mathematical model allowed us to link both the
nucleotide alterations with recorded CBF as a function of
Ca2+ concentration (Fig. 5). The action of Ca2+ is translated
into cilia movement via the sum of cAMP and cGMP bell-
shaped concentration proﬁles with maximum concentrations.
The trick here is that physiological intracilia concentration
varies mostly between the peaks of cAMP and cGMP, eﬀec-
tively forming the reversed bell-shaped dependence of CBF on
Ca2+ concentration. This result resolves the seeming incon-
sistency between reports suggesting that increasing Ca2+ may
48 | Mol. BioSyst., 2009, 5, 43–51 This journal is c The Royal Society of Chemistry 2009
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increase or decrease CBF. Thus, the underlying mechanism of
cilia movement in Paramecium represents an interesting
example of complementary roles in nucleotide-dependent
regulation, and also proposes an explanation for how intraci-
lia Ca2+ and nucleotide concentration alterations translate to
cilia movement, hence deﬁning the trajectory of Paramecium
motion.
The models presented suggest how the diversity of isoforms
of PDE, AC and GC within a single organism can give rise to
precise regulation of cellular activity and address the paradox
that alterations in Ca2+ concentrations can either increase or
decrease outputs over similar Ca2+ concentration ranges
depending on the cellular state. The model should be able to
help interpret the extraordinary evolutionary diversity, includ-
ing the absence, of PDE, AC and GC proteins, and the
complementary functions of diﬀerent isoforms. It may also
be valuable in revealing adverse or unexpected cellular re-
sponses to drugs or other inhibitors which, because of the
multiple isoforms and complex interactions of these proteins
related to signal-response proteins, may be otherwise unpre-
dictable and hard to measure experimentally.
Experimental
The model for intracellular cAMP metabolism
Fig. 1 provides a schematic outline of the network regulating
cAMP concentration that is considered in our model. The
cAMP production rate is proportional to the concentration of
AC molecules in the active state that form complexes with
adenosine triphosphate (ATP) and hydrolyse ATP to cAMP.
At the same time, PDE molecules constantly bind to cAMP
and degrade the phosphodiester bond, thereby converting
cAMP into inactive 50AMP. The intracellular level of cAMP
is deﬁned by the concentrations of AC and PDE isoforms in
the active state and their enzymatic activities. The major
regulators of AC are Ca2+ and signals mediated via G-protein
coupled receptors. Various AC isoforms have unique charac-
teristics in terms of their dependence on both Ca2+ and
G-proteins. Some of them are directly inhibited by Ca2+,
whereas other AC isoform activities are regulated by Ca2+
via calmodulin (CaM). The main activity regulator for cAMP
hydrolysing PDE isoform I is a Ca2+–CaM pair. In our
model, the law of mass action has been applied to derive a
model based on measurable parameters for the dependence of
cAMP levels on the AC and PDE enzymes. The chemical
reactions underlying cAMP production and further hydrolysis
are given by:
ATPþAC,k1
k1
ATPAC)k3 cAMPþACþ P
cAMPþ PDE,k2
k2
cAMPPDE)k4 50AMPþ PDE
ð1Þ
where ATP is adenosine triphosphate, AC is one isoform or a
combination of isoforms of AC, ATPAC is an ATP and AC
complex, PDE is one or a combination of isoforms of PDE,
cAMPPDE is a cAMP and PDE complex, 50AMP is physio-
logically inactive compound and P is pyrophosphate.
The reduced system of kinetic equations for the chemical
reactions in eqn (1) is given by:
d½cAMP
dt
¼ k3  ½ATPAC  k2  ½cAMP  ½PDE
þ k2  ½cAMPPDE
d½ATPAC
dt
¼ k1  ½ATP  ½AC  ðk1 þ k3Þ  ½ATPAC
d½cAMPPDE
dt
¼ k2  ½cAMP  ½PDE
 ðk2 þ k4Þ  ½cAMPPDE ð2Þ
The law of total mass conservation gives:
[PDE] + [cAMPPDE] = [PDE*] [AC] + [ATPAC]
= [AC*], (3)
where [PDE*] and [AC*] are the total numbers of active
molecules of PDE and AC, respectively.
Assuming that the alterations of [ATPAC] and [cAMPPDE]
complex concentrations are relatively small, and applying the
quasi-stationary approximation to eqn (2), we derive:
d½cAMP
dt
¼ k3  ½ATP  ½AC

K1 þ ½ATP
 
 k4  ½cAMP
 ½PDE

K2 þ ½cAMP ð4Þ
where
K1 ¼ k1 þ k3k1 ; K2 ¼
k2 þ k4
k2
Given that [ATP]44K1 in real cells (the ATP concentra-
tion is usually of the order of mM, whereas K1 is of the order
of mM), eqn (4) can be transformed to the following form:
d½cAMP
dt
¼ k3  ½AC  k4  ½cAMP  ½PDE

K2 þ ½cAMP ð5Þ
Eqn (5) has been solved under the steady-state assumption
to give:
cAMP ¼ K2  k  ½AC

½PDE  k  ½AC ð6Þ
In order to account for the diﬀerent biochemical properties of
the AC and PDE isoforms, we incorporate multiple AC and
PDE isoforms into eqn (6) as follows:
½AC ¼ ½AC0 
X
z
Zz  fzðCa2þ;mÞ
½PDE ¼ ½PDE0 
X
z
mz  gzðCa2þ; nÞ
ð7Þ
where [PDE*] and [A*] are the total number of PDE and AC
molecules respectively, [AC0] and [PDE0] are the total con-
centrations of each AC and PDE isoform respectively, and
Zz ¼
½AC0z
½AC0
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and
mz ¼ ½PDE0z½PDE0
are the fractions of each isoform of AC and PDE. The
dependence of the AC and PDE activities on Ca2+ is sepa-
rated from the G-protein dependence, which is denoted in the
above equations by m and n for AC and PDE, respectively.
Similarly, in steady-state, cGMP concentration can be
represented explicitly as a function of GC and PDE isoform
concentrations and activities by:
½cGMP ¼ K2  k  ½GC

½PDE  k  ½GC ð8Þ
In order to account for the diﬀerent biochemical properties of
the GC and PDE isoforms, we incorporate multiple GC and
PDE isoforms into eqn (8) as follows:
½GC ¼ ½GC0 
X
z
lz  fzðCa2þ; lÞ
½PDE ¼ ½PDE0 
X
z
nz  gzðCa2þ; nÞ ð9Þ
where [PDE*] and [G*] are the total number of PDE and GC
molecules respectively, [GC0] and [PDE0] are the total con-
centrations of each GC and PDE isoform respectively, and
lz ¼ ½GC0z½GC0
and
nz ¼ ½PDE0z½PDE0
are the fractions of each isoform of GC and PDE. The
dependence of the GC and PDE activities on Ca2+ is sepa-
rated from the G-protein dependence, which is denoted in the
above equations by l and n for GC and PDE, respectively.
The model for interactions between G-protein and Ca2+/CaM
signalling pathways
The ‘‘state’’ or activity of each AC molecule has been repre-
sented in our mathematical model as follows. In order to cover
all potential combinations, we assume that the molecule can be
in four diﬀerent states with diverse ratios of dissociation
constants:
1. v0 = 0.1, k0 = 1, 2. v1 = 100, k1 = 1, 3. v2 = 1,
k2 = 10, 4. v3 = 10, k3 = 0.1. (10)
In the above expression v0, v1, v2, v3 are the enzymatic activity
rates and k0, k1, k2, k3 are the Michaelis–Menten constants for
AC-substrate interactions. The probabilities for an AC mole-
cule to be in each of these four diﬀerent states are given by:
p0;0 ¼ Km1  Km2ðKm1 þ aÞ  ðKm2 þ bÞ
pa;0 ¼ a  Km2ðKm1 þ aÞ  ðKm2 þ bÞ
p0;b ¼ Km1  bðKm1 þ aÞ  ðKm2 þ bÞ
pa;b ¼ a  bðKm1 þ aÞ  ðKm1 þ aÞ
ð11Þ
where a and b are the concentrations of the G-protein subunits
and Ca2+-CaM complexes, respectively. Km1 and Km2 are the
Michelis–Menten constants for AC interactions with G-
protein subunits and Ca2+-CaM complexes, respectively.
P0,0, Pa,0, P0,b, Pa,b, are the probabilities for AC to be free,
in a complex with a G-protein subunit, bound to a Ca2+–CaM
complex, or bound to both a G-protein subunit and a
Ca2+–CaM complex, respectively.
The rate of cAMP production by AC in each of the diﬀerent
states is given by:
m0 ¼
v0  p0  S
k0 þ S ;
m1 ¼
v1  p1  S
k1 þ S ;
m2 ¼
v2  p2  S
k2 þ S ;
m3 ¼
v3  p3  S
k3 þ S :
ð12Þ
where S is substrate (ATP), v0, v1, v2, v3 are the enzymatic
activity rates, k0, k1, k2, k3 are the Michaelis–Menten con-
stants for AC-substrate interactions, and p0, p1, p2, p3 are the
probabilities in eqn (12).
The full activity of the molecule is given by:
M = m0 + m1 + m2 + m3 (13)
where m0, m1, m2 and m3 are the activities of individual AC
conformations in the states deﬁned by eqn (12).
Abbreviations
cAMP cyclic 30,50 adenosine monophosphate
cGMP cyclic 30,50 guanosine monophosphate
GC guanylate cyclase
PKA cAMP-dependent kinase
CBF cilia beat frequency
AC adenylate cyclase
PDE phosphodiesterase
ATP adenosine triphosphate
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